The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Gobert, Alain P ^a,b   Sagrestani, Giulia ^a   Delmas, Eve ^a   Wilson, Keith T ^b,c,d   Verriere, Thomas G ^b   Dapoigny, Michel ^e   Del'Homme, Christophe ^a   Bernalier Donadille, Annick ^a  

^a CEMAGREF   (France)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Veterans Affairs Tennessee Valley Healthcare System   (United States)

^e UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; DEXTRAN SULFATE;

ANIMAL; C57BL MOUSE; COLITIS; DYSBIOSIS; HUMAN; IMMUNOLOGY; INFLAMMATION; INTESTINE; INTESTINE FLORA; IRRITABLE COLON; MICROBIOLOGY; MICROFLORA; MOUSE; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS; CYTOKINES; DEXTRAN SULFATE; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION; INTESTINES; IRRITABLE BOWEL SYNDROME; MICE; MICE, INBRED C57BL; MICROBIOTA; RATS;

EID: 85006445951     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep39399     Document Type: Article

References (49)

1. Canavan, C., West, J., Card, T. The epidemiology of irritable bowel syndrome. Clin Epidemiol 6, 71-80 (2014).
2. Longstreth, G. F., et al. Functional bowel disorders. Gastroenterology 130, 1480-1491 (2006).
3. Moloney, R. D., et al. Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome. CNS Neurosci Ther (2015).
4. Foster, J. A., Lyte, M., Meyer, E., Cryan, J. F. Gut Microbiota and Brain Function: An Evolving Field in Neuroscience. Int J Neuropsychopharmacol (2015).
5. Rajilic-Stojanovic, M., et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792-1801 (2011).
6. Chassard, C., et al. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther 35, 828-838 (2012).
7. Crouzet, L., et al. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil 25, 12103 (2013).
8. Barbara, G., et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126, 693-702 (2004).
9. Barbara, G., et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132, 26-37 (2007).
10. Cenac, N., et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 117, 636-647 (2007).
11. Buhner, S., et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 137, 1425-1434 (2009).
12. Collins, S. M., Piche, T., Rampal, P. The putative role of inflammation in the irritable bowel syndrome. Gut 49, 743-745 (2001).
13. Kindt, S., et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil 21, 389-398 (2009).
14. Chang, L., et al. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol 107, 262-272 (2012).
15. Matricon, J., et al. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther 36, 1009-1031 (2012).
16. Chadwick, V. S., et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122, 1778-1783 (2002).
17. Cremon, C., et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 104, 392-400 (2009).
18. Tornblom, H., Lindberg, G., Nyberg, B., Veress, B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 123, 1972-1979 (2002).
19. Lee, K. J., et al. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 23, 1689-1694 (2008).
20. Braak, B., et al. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship? Am J Gastroenterol 107 (2012).
21. Kang, C. S., et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS One 8, e76520 (2013).
22. Anhe, F. F., et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 64, 872-883 (2015).
23. Holmen, N., Isaksson, S., Simren, M., Sjovall, H., Ohman, L. CD4+ CD25+ regulatory T cells in irritable bowel syndrome patients. Neurogastroenterol Motil 19, 119-125 (2007).
24. Willing, B. P., et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139 (2010).
25. Wang, W., et al. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol 52, 398-406 (2014).
26. Malinen, E., et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100, 373-382 (2005).
27. Krogius-Kurikka, L., et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 9, 95 (2009).
28. Lopez-Siles, M., et al. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes. Int J Med Microbiol 304, 464-475 (2014).
29. Vandeputte, D., et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65, 57-62 (2016).
30. Png, C. W., et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105, 2420-2428 (2010).
31. Vigsnaes, L. K., Brynskov, J., Steenholdt, C., Wilcks, A., Licht, T. R. Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls. Benef Microbes 3, 287-297 (2012).
32. Sokol, H., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105, 16731-16736 (2008).
33. Reunanen, J., et al. Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer. Appl Environ Microbiol 81, 3655-3662 (2015).
34. Derrien, M., Vaughan, E. E., Plugge, C. M., de Vos, W. M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucindegrading bacterium. Int J Syst Evol Microbiol 54, 1469-1476 (2004).
35. Everard, A., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110, 9066-9071 (2013).
36. Dao, M. C., et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65, 426-436 (2015).
37. Masui, R., et al. G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells. Inflamm Bowel Dis 19, 2848-2856 (2013).
38. Kim, M. H., Kang, S. G., Park, J. H., Yanagisawa, M., Kim, C. H. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145, 396-406 (2013).
39. Vivinus-Nebot, M., et al. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut 63, 744-752 (2014).
40. Kaser, A., Zeissig, S., Blumberg, R. S. Inflammatory bowel disease. Annu Rev Immunol 28, 573-621 (2010).
41. Vareille, M., et al. Heme oxygenase-1 is a critical regulator of nitric oxide production in enterohemorrhagic Escherichia coli-infected human enterocytes. J Immunol 180, 5720-5726 (2008).
42. Robert, C., Bernalier-Donadille, A. The cellulolytic microflora of the human colon: evidence of microcrystalline cellulosedegrading bacteria in methane-excreting subjects. FEMS Microbiol Ecol 46, 81-89 (2003).
43. Hamamoto, N., et al. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1). Clin Exp Immunol 117, 462-468 (1999).
44. Schloss, P. D., et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75, 7537-7541 (2009).
45. DeSantis, T. Z., et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 72, 5069-5072 (2006).
46. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200 (2011).
47. Engel, M. A., et al. Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide. J Physiol Pharmacol 59, 673-689 (2008).
48. Wu, H. G., et al. Regulatory mechanism of electroacupuncture in irritable bowel syndrome: preventing MC activation and decreasing SP VIP secretion. Dig Dis Sci 53, 1644-1651 (2008).
49. Viennois, E., Chen, F., Laroui, H., Baker, M. T., Merlin, D. Dextran sodium sulfate inhibits the activities of both polymerase and reverse transcriptase: lithium chloride purification, a rapid and efficient technique to purify RNA. BMC Res Notes 6, 360 (2013).